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Background: Pemphigus is a rare group of life-threatening mucocutaneous autoimmune blistering diseases.
Frequently, oral lesions precede the cutaneous ones. This study aimed to describe clinical and histological features
of oral pemphigus lesions in patients aged 18 years and above, attending outpatient’s facility of Khartoum Teaching
Hospital - Dermatology Clinic, Sudan. In addition, the study aimed to assess the diagnostic significance of routine
histolopathology along with immunohistochemical (IHC) examination of formalin-fixed, paraffin-embedded biopsy
specimens in patients with oral pemphigus.
Methods: A cross-sectional hospital-based study was conducted from October 2008 to January 2009. A total of 588
patients with confirmed disease diagnosis completed an oral examination and a personal interview. Clinical
evaluations supported with histopathology were the methods of diagnosis. IHC was used to confirm the diagnosis.
Location, size, and pain of oral lesions were used to measure the oral disease activity.
Results: Twenty-one patients were diagnosed with pemphigus vulgaris (PV), 19 of them (mean age: 43.0; range:
20–72 yrs) presented with oral manifestations. Pemphigus foliaceus was diagnosed in one patient. In PV, female:
male ratio was 1.1:1.0. Buccal mucosa was the most commonly affected site. Exclusive oral lesions were detected in
14.2% (3/21). In patients who experienced both skin and oral lesion during their life time, 50.0% (9/18) had oral
mucosa as the initial site of involvement, 33.3% (6/18) had skin as the primary site, and simultaneous involvement
of both skin and oral mucosa was reported by 5.5% (1/18). Two patients did not provide information regarding the
initial site of involvement. Oral lesion activity score was higher in those who reported to live outside Khartoum
state, were outdoor workers, had lower education and belonged to Central and Western tribes compared with their
counterparts. Histologically, all tissues except one had suprabasal cleft and acantholytic cells. IHC revealed IgG and
C3 intercellularly in the epithelium.
Conclusions: PV was the predominating subtype of pemphigus in this study. The majority of patients with PV
presented with oral lesions. Clinical and histological pictures of oral PV are in good agreement with the literature.
IHC confirmed all diagnoses of PV.
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Pemphigus is a group of chronic inflammatory auto-
immune bullous diseases. Although rare, they are poten-
tially life-threatening diseases that are associated with
high morbidity and mortality, if not properly treated [1,2].
The disease is associated with immunoglobulin (Ig) G and
complement factor (C) 3 antibodies against intercellular
adhesion structural components in the epithelium [3].
The immune reaction eventually breaks down the ad-
hesion components and leads to epithelial cell detach-
ment, which is clinically seen as intraepithelial blisters,
erosions or ulcers in the skin and mucous membranes
[4]. The underlying cause and activating mechanism
that initiates the immune response is unidentified.
However, both genetic and environmental factors have
been postulated to play a role in the pathogenesis of
pemphigus [5]. In this context, social habits like use of
traditional cosmetics and smoking have been impli-
cated [6-8].
Pemphigus has several subtypes, of which three have
been associated with oral mucosal involvement; pemphigus
vulgaris (PV), pemphigus foliaceus (PF), and paraneoplastic
pemphigus [9]. The first two subtypes are differing with
respect to the localization of intraepithelial blisters. In
PV, the blisters are located suprabasally, while in PF
they are more superficially located. Paraneoplastic pem-
phigus, although uncommon, is associated with internal
malignant neoplasia [10].
Oral lesions present as vesicles or bullae that quickly
break, leaving painful erosions or ulcers with irregular
borders; they most often affect buccal mucosa and gingi-
vae and heal slowly, without scarring. In PV, the oral le-
sions are reported as the initial sign of the disease in
50% of patients, yet these oral lesions have the greatest
resistance to efficient treatment.
PV is the most predominant type of pemphigus, affects
middle-aged adults without gender predilection [9,11-16]
and has an incidence varying from 0.76 to 32 per million
inhabitants per year [17-19]. While PV is a prevailing
diagnosis in the Mediterranean region, South Asia and
in the Jewish population [20,21], it is a rare disease in
Northern Europe, USA, South Africa and northern re-
gion of Africa [6,18,19,22-24]. Reports from Mali and
South Africa have shown that PV is rare in the black
ethnicity [22,24].
Diagnosis of pemphigus is based on careful correlation
of disease history and clinical findings with histopatho-
logic characteristics. Direct immunofluorescence (DIF)
on sections from a fresh frozen biopsy or indirect im-
munofluorescence (IIF) performed on patient’s serum
are important for verifying the diagnosis [25]. However,
in situations where IF is difficult to perform, immuno-
histochemistry (IHC) on formalin-fixed tissue samples
may be an alternative test to confirm the diagnosis [26].A study conducted in a dermatology clinic of
Khartoum Teaching Hospital (KTH) in Sudan in 1998,
focusing mainly on skin lesions, showed that PV was the
dominant variant of pemphigus, constituting 88% of all
cases diagnosed [27]. According to that study, oral mu-
cosa was the second most common site of the lesion to
occur after the trunk. The highest frequency of PV was
found in the third decade of life [27]. Another study
conducted in the same clinic in 2008, revealed a preva-
lence of oral PV of 2.8% among skin diseased outpatient
attendees [28]. This study also showed that the fre-
quency of oral PV among patients with skin disease
with any oral mucosal lesions was 4.8%. In both stud-
ies, clinical information and conventional histological
examination of biopsies using haematoxylin and eosin
(H&E) staining were the only methods for diagnosing
skin lesions.
Sudan is a large country with a multi-cultural multi-
ethnic society. The prevailing ethnicities are Arabic and
African, with hundreds of tribal divisions. The epidemio-
logic profile is typical of Sub-Saharan African countries;
malaria, infectious diseases, hypertension, diabetes melli-
tus, and nutrition disorders are among the prominent
diseases treated in the health units of Sudan [29]. On
the basis of these considerations and due to the scarce
information available regarding pemphigus in sub-
Saharan African populations, the present study, present-
ing a further analysis of the data conducted in 2008 [28],
aimed to describe clinical presentation of patients with
oral pemphigus attending the dermatologic clinic of
KTH. Given the fact that conventional histology was the
only diagnostic tool in public hospitals in Sudan, the
study also evaluated the diagnostic significance of com-
bining this technique with IHC analysis of the formalin-
fixed, paraffin-embedded oral biopsy specimens.
Methods
Sampling procedure
A cross sectional hospital based study was carried out
focusing on patients aged ≥18 years with mucocutaneous
diseases, attending an outpatient dermatologic clinic at
KTH from October 2008 to January 2009. KTH is the
largest national hospital in Sudan, located in Khartoum,
the capital city. It is an open public and referral hospital,
receiving patients from all the states of the country. For
the present study, a minimum sample size of 500 pa-
tients was calculated based on an assumed prevalence of
oral mucosal lesions (OML) in patients with skin dis-
eases of 5%, a confidence interval of 95%, and an abso-
lute precision of 0.02 [30]. All patients (n = 4235)
attending the outpatient facility during the survey period
were invited to participate in the study. A total of
1540 subjects (36.4%) initially accepted to participate.
Fear of taking biopsy for asymptomatic lesions and
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view, and biopsy when needed) were the main reasons
for not volunteering to participate. Of those who ini-
tially accepted to participate, 588 (588/1540, 38.1%)
patients were finally included in the study.
Confidentiality of the patients was maintained, partici-
pants were informed about their oral conditions, and
health education was provided. Those who needed den-
tal services were referred to the clinics of the Faculty of
Dentistry, University of Science and Technology (UST),
Umdurman, for further investigation and management.
Written informed consent or finger print (illiterates) for
participation and publication of the study was obtained
from patients or their parents/guardians. The research
conformed to the Helsinki Declaration, and ethical clear-
ance and approval letters were obtained from the partici-
pating institutions’ committees in Sudan (UST and KTH,
Department of Dermatology) and Norway (The Regional
Committee for Medical Research Ethics of Western
Norway).
Socio-demographic characteristics and clinical
examination
A structured questionnaire was administered by two trained
dentists in face to face interviews. Socio-demographic
characteristics were measured in terms of gender, age,
tribe, occupation, marital status, place of residence and
oral habits. Participants were also asked about history of
PV among first-degree relatives (parents, grandparents,
siblings, children, and grandchildren). Medical condition
and treatment were assessed according to the following
conditions: heart diseases, hypertension, asthma, diabetes,
liver diseases, hepatitis /jaundice, anaemia, bleeding disor-
ders, kidney diseases, rheumatoid arthritis, allergy, cancer,
epilepsy, stomach ulcer, intestinal disorders, respiratory
disorders, pregnancy, psychiatric treatment, radiotherapy
and chemotherapy. Furthermore, the patients were asked
if their medical condition was diagnosed by a specialist
and if they were under medication.
An expert dermatologist (HS) evaluated the patient’s
skin diseases based on history of the disease and clinical
findings, and the diagnosis was subsequently confirmed
by histological examination when it was considered ne-
cessary. Details of involved sites at presentation and clin-
ical course of the lesions were registered.
Systematic comprehensive extra-oral and intra-oral clin-
ical examinations based on visual inspection and palpa-
tion, following the World Health Organization (WHO)
criteria for field surveys [31], were carried out by a dentist
(NMS) who received a training in diagnosis of OML be-
fore the data collection (The Gade Institute, Section for
Pathology, and Department of Clinical Dentistry, Section
for Oral Surgery and Oral Medicine, University of Bergen,
Norway). An OML was defined as any abnormal changeor any swelling in the oral mucosal surface. Diagnostic
criteria for OML were based on Axéll’s criteria and
those defined in former studies and reviews [31-33].
The oral clinical examination and additional informa-
tion with respect to OML and oral habits have been re-
ported elsewhere [28]. Data on location, size, clinical
presentation of the oral lesion (vesicle, erosion/ulcer)
and clinical course were recorded. Skin lesions and oral
lesions were encountered during the survey and were
photographed using a digital camera (Canon EOS
400D). Final diagnoses of all biopsies were given by an
expert oral pathologist (ACJ).Assessment of clinical oral lesions’ activity
To assess the clinical severity of the oral lesions, an oral
lesion activity score (OLAS) was constructed. The score
was based on three components. Firstly, clinical exten-
sion of the OML was assessed. A modified system based
on an established protocol [34] was used to register the
extension of an oral lesion at10 anatomical locations;
upper lip, lower lip, gingival mucosa, unilateral buccal
mucosa, bilateral buccal mucosa, tongue, floor of the
mouth, hard palate, soft palate and oropharynx. Each lo-
cation was assessed as 0 = no lesion, 1 = presence of le-
sion, resulting in a total score ranging from 0 to 10.
Secondly, size of the lesion was determined according to
the largest diameter of a lesion at any location present at
examination and scored as; 1 < 1 cm, 2 ≥ 1 cm. Thirdly,
severity of symptoms was evaluated by asking patients to
describe any pain associated with eating and drinking
and was reported as: 0 = no pain, 1 =mild to moderate
pain, and 2 = severe pain. Based on a former report [35],
the OLAS for each patient was constructed as the sum
of objective score (location, size) and subjective score
(pain), ranging from 1 to 14, and reported in terms of
means.Assessment of oral tissue biopsy
Oral tissue biopsies were taken from the periphery of
the lesions. The tissue was fixed in formalin and embed-
ded in paraffin. Sections were stained with hematoxylin
and eosin (H&E) and examined using light microscope.
To evaluate inflammation, number of inflammatory cells
(mononuclear and polymorphonuclear cells) in the
superficial parts of the connective tissue adjacent to the
tip of the epithelial rete ridges, were counted in 6 ran-
dom fields (one field = 250 μm2) per section using an
ocular grid and high power magnification (40 ×). The in-
flammatory cells were counted 3 times per each field,
and results were expressed as a mean per specimen
(mean ± SD/1500 μm2). The variation of degree of in-
flammation between specimens was evaluated.
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paraffin-embedded oral tissue
IHC for IgG and C3 was performed on formalin-fixed,
paraffin-embedded oral mucosal specimens from 11 pa-
tients. Sections, 4 μm-thick, were cut on a Leica RM2155
microtome and mounted on glass slides (Super Frost Plus,
Gerhard Menzel Gmbh, Germany) and heated at 56°C
overnight. The sections were deparaffinized in xylene and
rehydrated in alcohol. For C3c, sections were incubated in
target retrieval solution (pH6, S1699, DAKO, Glostrup,
Denmark), microwaved for 15 minutes after the buffer
had come to a boil, then let to cool down on bench and
thereafter washed slightly under running tap water for
5 minutes. Primary anti-human C3c polyclonal rabbit
compliment (A0062, DAKO) at 1:15000 dilutions was
incubated for 30 minutes at room temperature. For IgG,
sections were incubated in epitope retrieval solution
(proteinase type XXIV bacterial, Sigma P 8038 37) for
10 minutes at 37°C. Primary antibody polyclonal rabbit
anti-human IgG (A 0423, DAKO) at 1:60000 dilutions
were incubated for 60 minutes. Endogenous peroxidase
activity was blocked by 0.03% hydrogen peroxide (H2O2)
(S2023, DAKO) for 7 minutes. Detection was performed
using peroxidase labeled polymer conjugated to goat anti-
rabbit/mouse immunoglobulins (K5007, Envision +W,
DAKO) for 30 minutes. Between each of the above steps,
sections were washed with tris-buffered saline with Tween
(TBST, pH 7.6, S3306, DAKO) for 10 minutes. Reaction
was then visualized using 3, 3′- diaminobenzidine (DAB)
(K5007, DAKO). The sections were thereafter counter-
stained with hematoxylin (S3301, DAKO), dehydrated and
mounted with a non-aqueous mounting medium (Eukitt,
O.Kindler GmbH & Co., Freiburg, Germany).
Statistical analysis
Descriptive statistical analysis was done using PASW
Statistics version 18.0 (SPSS Inc., Chicago, USA).
Results
A total of 588 outpatients participated in the study. Out
of those participants, there were 22 patients with pem-
phigus, where PV was the most frequent disease (95.4%,
21/22) followed by PF (4.5%, 1/22). Fourteen patients
(63.6%, 14/22) were already diagnosed, coming with new
active lesions, while 7 patients (31.8%, 7/22) were newly
diagnosed cases. In one patient there was no information
about disease history. Of the 588 patients, 359 had at
least one type of OML, while oral PV was registered in
19 patients.
Demographic features of patients with oral PV
Of the 19 patients diagnosed with oral PV (mean age
43.0, range 20–72 yrs), 10 were females (mean age,
35.8 yrs) and 9 were males (mean age, 38.3 yrs). None ofthe females were pregnant. As shown in Table 1, the ma-
jority of the patients were <50 yrs (68.4%), low education
(84.2%), married (77.8%), had outdoor jobs (52.6%), and
were residing outside the Khartoum state (57.9%). Pa-
tients who reported Western tribes were 47.4% (9/19)
compared to 21% (4/19) from Northern tribes, 26.3%
(5/19) from Central tribes and only one reported Southern
tribes. Totals of 11.1%, 21.1%, and 10.5% confirmed use of
toombak, smoking and use of alcohol, respectively. These
habits were exclusively reported by males.
History and aggravating factors
Negative family history (first degree- relatives) was re-
ported by all patients. The systemic conditions reported
by the patients included hypertension (5 patients), intes-
tinal problems (4 patients), and allergy, anaemia, arth-
ritis, and diabetes each was reported by 3 patients.
Moreover, peptic ulcer, hepatitis, thyroid and liver dis-
eases were reported by one patient each. No neoplastic
diseases were recorded. Aggravating factors like eating
spicy food, stress and smoking were reported by 3 patients.
Concerning medications, one patient had taken penicillin
and another one co-trimoxazole before eruption of the
disease. All patients were scheduled to be treated with sys-
temic steroids.
Clinical presentation of oral lesions of PV
At time of examination, 76.1% (16/21) of the patients
with PV had both oral and skin lesions. Exclusively oral
lesions were observed in three females 14.2% (3/21), and
a former history of skin lesions was reported by two of
them. In patients who experienced both skin and oral le-
sions during their life time, 50.0% (9/18) had oral mu-
cosa as the initial site of involvement, 33.3% (6/18) had
skin as the primary site, and simultaneous involvement
of both skin and oral mucosa was reported by 5.5% (1/18).
Two patients did not provide information regarding the
initial site of involvement. In addition to oral lesions, ex-
tremities and trunk were the most common cutaneous
sites involved followed by scalp, genitalia and eyes. As
shown in Figure 1, bilateral buccal mucosa was the most
commonly affected site followed by hard palate. The
sites least affected were oropharynx and unilateral buc-
cal mucosa. The clinically predominant oral lesions
were mucosal erosions and ulcers. Vesicles were evident
in one patient only.
Oral lesions which were > 1 cm in diameter were regis-
tered in 52.6% (10/19), and those which were ≤ 1 cm in
diameter were registered in 47.4% (9/19) of patients.
Pain was reported as severe by 43.8% (7/16), moderate
by 37.5% (6/16) and no pain by 16.7% (3/18) of patients.
Missing information was noted in each category of pain
description. With respect to the OLAS total scores,
scores 3 and 4 were registered in one patient each
Table 1 Socio-demographic distribution of study participants with oral PV according to gender and means of oral
lesions activity scores (OLAS)
Female Male OLAS
n (%) n (%) n (Mean ± SD)
Age
< 50 years 8 (80.0) 5 (55.6) 11 (8.7 ± 3.5)
≥ 50 years 2 (20.0) 4 (44.4) 5 (8.6 ± 2.3)
Education
Low education (illiterate + primary) 9 (90.0) 7 (77.8) 13 (9.3 ± 2.8)
High education 1 (10.0) 2 (22.2) 3 (6.0 ± 3.0)
Marital status
Unmarried 2 (20.0) 2 (25.0) 4 (8.0 ± 3.7)
Married 8 (80.0) 6 (75.0) 11 (8.7 ± 3.1)
Occupation
Indoor job (professional, skilled labour and unemployment) 6 (60.0) 3 (33.3) 7 (6.7 ± 3.2)
Outdoor job (farmer, animal breeder, street seller and builder) 4 (40.0) 6 (66.7) 9 (10.2 ± 2.0)
Tribal distribution
Northern region 2 (20.0) 2 (22.2) 4 (5.7 ± 2.0)
Southern region 1 (10.0) 0 1 (7.0)
Western region 5 (50.0) 4 (44.4) 8 (9.6 ± 3.0)
Central region 2 (20.0) 3 (33.3) 3 (10.6 ± 2.5)
Residence during last 5 years
Khartoum state 5 (50.0) 3 (33.3) 6 (6.1 ± 2.3)
Out of Khartoum state 5 (50.0) 6 (66.7) 10 (10.2 ± 2.5)
Habits
Toombak user 0 2 (25.0) 1 (6.0)
Non-user 10 (100) 6 (75.0) 14 (8.8 ± 3.2)
Smoker 0 4 (44.4) 4 (8.0 ± 0.8)
Non-smoker 10 (100) 5 (55.6) 12 (8.9 ± 3.5)
Alcohol user 0 2 (22.2) 2 (7.5 ± 0.7)
Non-user 10 (100) 7 (77.8) 14 (8.8 ± 3.3)
The total number in the different categories did not add to 19 owing to missing values.
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recorded in two patients each (12.5%). The total mean of
the OLAS was 8.27 (range 3–13).
As shown in Table 1, the mean of the OLAS was high
with those who resided out of Khartoum state and with
outdoor workers (10.2) compared with those living in
Khartoum state (6.1) and indoor workers (6.7). Also, it
was high with lower education (9.3) compared to higher
education (6.0), and with those who reported Central
(10.6) and Western (9.6) tribes compared to other tribes
from Northern and Southern parts of Sudan.
Microscopic examination
Eleven out of 16 patients with oral lesions agreed to have
a biopsy taken. The histological characteristics were
comparable in all tissue specimens. Ten out of elevenbiopsies were covered by non-keratinized epithelium.
Few inflammatory cells (lymphocytes and neutrophils)
were present in the superficial epithelial layer of 5 biop-
sies. No candida hyphae could be demonstrated by PAS
staining. Nearly all biopsies demonstrated spongiosis in
the lower spinous cell layers, in addition to presence of
neutrophils and lymphocytes in 6 biopsies. Apoptotic
cells were seen in the spinous layer of 3 specimens.
Suprabasal epithelial clefts were detected in 10 out of
11 biopsies, while one patient biopsy showed spongiosis
only. However, in that patient, the diagnosis of PV was
based on histopathology of a skin biopsy. In some sec-
tions, 1 to 2 layers of suprabasal keratinocytes were at-
tached to basal cells forming part of floor of the cleft. In
6 biopsies, the clefts were especially seen on the tip of
the epithelial rete ridges (Figure 2). The basal cells
Figure 1 Distribution of oral manifestations in patients with pemphigus vulgaris.
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same section as well as between sections, displaying
complete loss of intercellular attachment (tombstones)
or showing intact attachment, where all basal cells
remaining attached to the basement membrane and lam-
ina propria. Inside the cleft, partially and completely de-
tached keratinocytes (acantholytic cells) from the basal
and lower prickle cells layers were spotted as single cells
or clusters. In addition, lymphocytes and neutrophils
were the main inflammatory cells inside the cleft.
In all tissue sections, the superficial parts of the con-
nective tissue were characterized by edema, small blood
vessels, loose fiber arrangements and both interstitial
and perivascular inflammatory infiltrates. MononuclearFigure 2 Histology of oral mucosa of pemphigus vulgaris
shows acantholysis in the lower spinous cell layers. Basal layer
cells are attached to the connective tissue and suprabasal cleft are
seen at the tips of the epithelial rete ridges (scale = 200 μm).cells were the principal inflammatory cells, and there
were only few neutrophils and eosinophils. The total
number of mononuclear cells varied across the 6 fields
for each specimen (Table 2), from 151 cells (mean: 25.1 ±
4.2; range: 22–31 cells) to 407 cells (mean: 67.8 ± 10.2;
range: 53–79 cells). Mononuclear cells in the specimens
were not influenced by the level of the OLAS. Deeper in
the connective tissue, mast cells and perivascular mono-
nuclear cell infiltrates were seen in 7 specimens.
Immunohistochemistry
IgG and C3 were detected intercellularly in the epithe-
lium of all specimens examined. The staining was stron-
gest in the suprabasal layer of the epithelium (Figures 3
and 4).
Discussion
This is the first study to report on the clinical character-
istics of patients with oral pemphigus in Sudan, specific-
ally in outpatients of a dermatology clinic in KTH. In
this study, the prevailing variant of pemphigus was PV
(95.4%), and oral mucosal involvement was present in
90.4% of the patients. An initial oral involvement was re-
ported by 50% of those with both skin and oral lesions.
The majority of the patients were in their fifth decade of
life. Palate and buccal mucosa were the most common
locations followed by tongue and lower lip. Based on the
OLAS, the highest severity of the oral lesions was found
in patients with low education, having outdoor jobs,
from Central and Western tribes, living out of Khartoum
state and being non-smokers. The histopathological pic-
tures of all specimens were in agreement with the IHC
findings. However, our findings should be interpreted
with caution since several limitations were inherited in
Table 2 Distribution of mononuclear cells in the superficial parts of the connective tissue adjacent to the tip of the
epithelial rete ridges (6 random fields per section)
Patients Number of mononuclear cells Sum (Mean ± SD) Range
Area 1 Area 2 Area 3 Area 4 Area 5 Area 6
1 68 26 32 66 38 85 315 (52,5 ± 23,7) 26–85
2 40 45 33 35 44 38 235 (39,1 ± 4,7) 33–45
3 30 22 22 31 22 24 151 (25,1 ± 4,2) 22–31
4 44 15 18 39 43 60 219 ( 36,5 ± 17,0) 15–60
5 47 28 19 13 16 48 171 (28,5 ± 15,5) 13–48
6 36 37 44 43 32 84 276 (46 ± 19,1) 32–84
7 48 28 49 42 46 45 258 (43 ± 7,7) 28–49
8 24 19 13 28 29 50 163 (27,1 ± 12,6) 13–50
9 53 79 77 73 60 65 407 (67,8 ± 10,2) 53–79
10 75 38 45 44 73 70 345 (57,5 ± 16,8) 38–75
11 70 50 50 24 47 60 301 (50,1 ± 15,3) 24–70
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sign of this study and the small sample size of the study
populations hindered statistical evaluation of the findings.
In addition, the relatively short period for data collection
and the potential effect of selection bias were considered
to influence the results and limit generalization. While the
KTH is one of the largest national referral hospitals in
Sudan, other referral and private hospitals could also re-
ceive patients from other parts of Khartoum and the rest
of the country. In spite of the limitations mentioned
above, the study may be beneficial as a first step in study-
ing a new issue and to generate hypotheses.
Pemphigus is primarily considered to be a dermatologic
disease. The fact that PV commonly and initially affects
the oral mucosa and then the skin [16], gives dentists a
great opportunity to detect the disease at an early stage.Figure 3 Immunohistochemistry staining used to detect IgG in
formalin-fixed, paraffin-embedded oral tissue biopsy from
patients with pemphigus vulgaris. IgG (brown colour) is seen in
the intercellular junction of keratinocytes reliable with the location
of desmoglein 3 (scale = 50 μm).The present study showed that 90.4% of the patients had
oral mucosal lesions, which is in accordance with a previ-
ous report [36]. Moreover, a multicentre study by Brenner
et al. [37], found varying prevalence of oral lesions in pa-
tients with PV; 66% in Bulgarian patients, 83% in Italian,
and 92% in Israeli patients. Our result is higher than those
reported by Ramirez et al. [38], who found a prevalence of
18% of oral lesions in PV patients examined in a dermato-
logic clinic in Mexico City.
Generally, PV has been reported to affect men and
women equally [9]. Several studies registered the highest
frequency in females [21,39-46], while a few studies have
reported males’ dominance [41,47]. In general, estrogen
(exogenous and endogenous) has been accused for the
females’ predominance in autoimmune diseases [48].
Supporting the hypothesis, 80% of the females in theFigure 4 Immunohistochemistry staining used to detect C3 in
formalin-fixed, paraffin-embedded oral tissue biopsy from
patients with pemphigus vulgaris. C3 (brown colour) is seen in
the intercellular junction of keratinocytes reliable with the location
of desmoglein 3 (scale = 50 μm).
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old). A prospective case–control study among Tunisian
females found that traditional cosmetics, commonly used
after marriage (henna, kohl, souak), was associated with
occurrence of pemphigus diseases in younger women [6].
In that respect, we found that 80% of women were mar-
ried. Sudanese married women use on daily basis trad-
itional home-made cosmetics like skin exfoliating scrub
paste, oils, perfumes, henna, and smoke-baths, beside
modern cosmetic skin whiteners, which are used among
both married and single women.
Evidences from Western countries indicate that auto-
immune diseases are increasing in frequency and show a
female predominance [48,49]. Accordingly, some authors
hypothesized that this could be, at least partially, attrib-
utable to new or modified patterns of exposure to che-
micals, including environmental estrogens [48]. Many
organochlorine pesticides are suspected to impair nat-
ural hormonal function in organisms by mimicking en-
dogenous estrogen. The hypothesis proposes that the
impact of pesticides and gardening materials on estro-
gen metabolism can trigger pemphigus. Our result
showed that among outdoor workers, farming was the
outdoor job most frequently reported. One may specu-
late that beside sun exposure, environmental estrogens
may affect specific population with a susceptible genetic
background.
Traditionally, PV tends to appear between the ages of
40 and 60 years [9]. In the present study the mean age
was 43 years, close to findings from Thailand, Spain and
Korea [15,42,50], but lower when compared with data
given from countries like Romania, Germany and North
America [51-53] and higher than other countries like
Kuwait and Iran [14,54].
Educational achievement is connected with better em-
ployment and income, which in turn can affect health
behaviors and access to health facilities and thus treat-
ment in appropriate time [55]. That could partially ex-
plain the higher frequency of PV and the higher OLAS
mean values among the low educated group as well as
outdoor job workers in comparison to their counterpart.
In addition, outdoor workers are likely to be exposed to
sun light and UV radiation for a long time of the day.
The band of the UV radiation has been suggested to in-
duce pemphigus [56,57]. Also, heat might be necessary
to liberate a sufficient amount of PV antigen from epi-
thelium [58]. Moreover, mid latitude, subtropical and
tropical countries have been suspected to have higher
frequency of pemphigus than other countries. Thus,
higher incidence was found in Mediterranean countries
[20,59] compared to high latitude countries like Finland
and North America [18,19]. An epidemiological study
from Greece demonstrated that high temperatures and
extreme sun exposure raise the relapse frequency of PV[59]. Another study from South Africa observed exacerba-
tion of pemphigus during summer time [24]. In connec-
tion with that, Sudan is located between latitude 4 to 22
degrees north, characterized by an environment range
from tropical climate in the south, to savannah and desert
in the central and northern area where temperature nor-
mally exceeds 40°C, especially during summer [60,61].
Controversially, one study from Iran showed that higher
rate of disease onset was in winter [54]. Another study
from Tehran found that there was no significant differ-
ence of disease onset or recurrence among annual sea-
sons, indicating that genetic and racial variations might
play a more important role than climate differences in the
pathogenesis of PV [62].
PV was the predominant variant of pemphigus in the
present study (95.4%). This was in accordance with sev-
eral previous studies [11-15], but opposing data from
some African regions (Mali, South Africa, Tunisia and
Libya) where PF was the dominant variant [22-24,63].
The data from Mali and South Africa proposed that PV
is rarely seen in black African ethnicity. Sudan has two
ethnic groups; Afro-Arab tribes and non-Arab African
tribes, where Southern tribes belong to the latter one. In
the present result, PV was registered in only one patient
from Southern tribes of Sudan compared to 9 (47.4%)
from Western tribes (Afro-Arab and non-Arab African
tribes). Yet the disease was not registered in Sudanese
Eastern tribes (non-Arab African tribes) which lead to un-
explained results. Several heterogeneous factors have been
implicated of inducing or triggering pemphigus in different
ethnic populations including genetic factors, in particular
Human Leukocyte Antigen (HLA) class II loci. That has
been noted in Ashkenazi Jews, Iranian, Italian patients and
also in patients of South Asian and Mediterranean origin
[64,65]. In comparison, the disease seems to be rare in
Northern Europe and USA. However, genetic factors alone
is not enough to initiate the autoimmune reaction as dem-
onstrated by a report of PV in only one of two monozy-
gotic twins [66]. Our data showed an absence of PV in
first degree relationship. This is supported by the paucity
of familial PV reports in the literature as reviewed by
Tetsuya et al. [67]. It is conceivable that exogenous factors
might induce PV in genetically predisposed individuals.
Cigarette smoking has been a highly controversial topic
with respect to effect on certain autoimmune diseases. Al-
though it is considered one of the leading morbidity and
mortality risk factors [68], some clinical evidence has sup-
ported its beneficial and protective effect on patients with
pemphigus [69] and certain diseases such as ulcerative
colitis and recurrent aphthous ulcers [70,71]. Thus, smok-
ing history is an essential factor in pemphigus patients. A
case control study by Brenner et al. [37], reported that risk
for PV was lower in current and ex-smokers than for pa-
tients who had never smoked. It has been shown that
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cyte adhesion by increased motility, proliferation and lat-
eral migration. That would increase re-epithelialization
and rapid wound healing. On the other hand, opposite re-
sults were shown when patients were subjected to chronic
or long-term exposure to nicotine [72,73]. The effect of
chronic exposure to nicotine was shown to reduce cutane-
ous blood flow and inhibit and decrease fibroblast migra-
tion in wound healing and to induce wound infection
[74,75]. Moreover, immunosuppressive effects in terms of
reduction in immunoglobulins, helper/suppressor T-cell
ratios, lymphocyte transformation and natural killer cell
cytotoxicity could also delay the healing process. Never-
theless, varying outcomes are still recorded [76]. In as-
sociation with that, the present study showed that
smoking was exclusively reported by males and in only
21.1% (4/19) of the patients. Although non-smokers and
smokers registered similar OLAS means, the latter were
the less frequent.
In this study, patient’s medical history revealed some
medications that were taken before the disease eruption
such as penicillin, co-trimoxazole and anti-hypertensive
drugs, indicating a possible association, which has also
been suggested in other studies [5,77,78].
The present results showed that half of the patients
with oral lesions had experienced the first lesion in the
mouth followed by skin lesions. This is in accordance
with a study performed in India (53.5%) [79]. The 14.2%
(3/21) of patients with exclusively oral lesion found in
our study is comparable to 16.5% from Iran [80], but in
contrast to 86% found in Northern Greece [44]. Exclu-
sively oral lesions tend to be a marker for less virulent
disease and a better prognosis [81]. It is uncommon to
clinically identify vesicles or bullae in the oral mucosa
due to continuous mechanical forces that characterize
the normal activity of the mouth. Beside the thin and
fragile roof of the PV bullae, irregular erosions and ill-
defined ulcers were the principal clinical features of oral
PV. Our findings notified only one patient with bullae,
contradicting a Brazilian study that found a rate of 75%
of patients with clinically identifiable vesicles [82]. The
distribution of oral lesions in our PV patients followed
the international literature showing the most common
sites were palate, buccal mucosa, tongue and lower lip
[83]. Other studies found the gingiva to be the most com-
monly affected site [84,85]. Although gingival lesions are
uncommon at the onset, they usually manifest as severe
desquamative or erosive gingivitis in advanced stages of
PV [86].
Based on histology, we were able to confirm the diag-
nosis in 10 out of 11 specimens. The microscopic exam-
ination was found to be comparable with the classic
histology of PV as described in the literature. This result
reinforces previous suggestions, that oral lesions ofpemphigus preserve the histologic features of acantholy-
sis more than in skin lesions, and they are less prone to
bacterial infections than skin, where secondary infec-
tions may affect the definitive histologic pattern [87].
Oral ulcers were the main clinical characteristic features
of the patients in this study. Therefore, to demonstrate
the typical pathologic changes in PV, all specimens in
the present study were taken from intact oral mucosa
immediately adjacent to the lesions. Considering inflam-
matory infiltrates, the results showed that mononuclear
cells were the principal inflammatory cells in all speci-
mens, confirming the chronic nature of PV. Further-
more, evidences have shown that lymphocytes play a
critical role in immune surveillance and activation in
PV. Lymphocytes have been reported to produce specific
cytokines that may be critical for the launch and con-
tinuation of the production of Dsg3-specific autoanti-
bodies by B lymphocytes [88,89]. Our results showed
moderate variations in the numbers and means of in-
flammatory cells from one specimen to another, as well
as in the range of cells within one specimen. These re-
sults are in consistence with the literature [10].
Tzanck smear to detect acantholytic cells is used as a
screening procedure and rapid test for diagnosing oral
PV [90]. A recent report has shown that Candida smear
using methylene blue was useful in detecting acantholy-
tic cells in such cases [91]. Some studies found that the
efficacy of H&E staining alone in diagnosing PV is prob-
ably greater than 90% and could be considered satisfac-
tory [92,93]. However, ambiguous cases and treatment
planning remain challenging. Equivocal cases come from
a number of conditions that are expressed as oral vesi-
cles or bullae that rapidly rupture and result in erosions
or ulcers. Some are viral infections such as herpes sim-
plex infection, while others are immunologic diseases
like pemphigus, pemphigoid, lupus erythematosus and
lichen planus. In such cases, DIF and IIF are important
to discriminate between them, confirm diagnosis and
plan proper treatment. Limitations of these techniques
are the availability of blood serum or fresh frozen tissue
that requires specific facilities to perform, and they do
not always exist in all health services, especially in devel-
oping countries. It also is important to secure safe trans-
port to laboratories using correct media that prevent
autolysis of the tissue. In addition, it is costly and thus
not affordable for all patients. Thus, pathologists in
Sudan usually receive patients’ specimens that have been
fixed in formalin or normal saline [94]. To overcome
these limitations, a previous study applied DIF on
formalin-fixed, paraffin-embedded tissue [95]. Although
the technique was less sensitive than when using frozen
tissue, the possibility of misclassification was low. An-
other study using immunoperoxidase staining technique
on formalin-fixed, paraffin-embedded tissue from PV
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globulin in the absence of microscopic features of the
disease [96]. Our study demonstrates that IHC on
formalin-fixed, paraffin- embedded tissue is a reliable
method to confirm the diagnosis of PV. At the time of
the present study, and specifically in public hospitals in
Sudan, confirmation of the PV was based on clinical
examination, anamnesis and conventional histopath-
ology. Thus, IHC enhances the accuracy of diagnosing
PV and can be used when only formalin-fixed, paraffin-
embedded tissue is available for analysis.
Conclusion
PV was the predominating subtype of pemphigus in this
study. The majority of PV presented with oral lesions.
The results of this study are in agreement with the pre-
vious studies with respect to the age, gender, oral lesions
distribution and first presentation of PV. The aetiology
of PV is uncertain, but several heterogeneous factors
could implicate to its pathogenicity. IHC in formalin-
fixed, paraffin-embedded oral tissue biopsy confirmed
the diagnosis of PV. The current study shed light on the
higher prevalence of oral PV among the study popula-
tion, suggesting that great collaboration efforts between
dermatologists and dentists would provide better treatment
and avoid serious sequelae and death.
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